procainamide has been researched along with Hypersensitivity, Type III in 4 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, RE | 1 |
| Sim, E | 2 |
| Lambert, PH | 1 |
| Creighton, D | 1 |
| Goodman, R | 1 |
| Bankhurst, A | 1 |
| Mischer, PA | 1 |
2 reviews available for procainamide and Hypersensitivity, Type III
| Article | Year |
|---|---|
Drug-induced immune complex disease.
Topics: Amino Acid Sequence; Antigen-Antibody Complex; Complement Activation; Complement C4; Humans; Hydrala | 1991 |
Drug-induced immune-complex disease.
Topics: Humans; Hydralazine; Immune Complex Diseases; Isoniazid; Lupus Erythematosus, Systemic; Penicillamin | 1989 |
2 other studies available for procainamide and Hypersensitivity, Type III
| Article | Year |
|---|---|
Procainamide, acetylprocainamide, and drug-induced lupus erythematosus.
Topics: Acecainide; Humans; Immune Complex Diseases; Lupus Erythematosus, Systemic; Procainamide | 1979 |
[Experimental approach to the pathogenesis of systemic lupus erythematosus].
Topics: Animals; Antigen-Antibody Complex; Autoantibodies; Cyclophosphamide; Disease Models, Animal; DNA; Fe | 1972 |